CENTIVIS combines well proven, pharmaceutical market access methodology with specific diagnostics knowledge, tested in real-life, industry setting. Innovative medicines have mastered capturing the true value of their products. How can your diagnostic solution also claim the fair value of providing precious medical insights?
We know how hard it is to stay ahead of the curve to develop, commercialize differentiated diagnostic solutions and to capture their fair value. The operating environment is getting more complex, tech companies enter the market, digital diagnostic solutions challenge the status quo, regulators and payers increase policy scrutiny and tests require more and better clinical evidence.
CENTIVIS, a Boutique Diagnostics and Digital Health Market Access, Policy Consulting was founded by Norbert Farkas. Prior starting his own firm, Norbert supported multiple innovative pharmaceutical, vaccines and in-vitro diagnostics product launches from the access and policy perspectives at Novartis and Roche Global Headquarters in Switzerland. He started his career at the European Parliament. By serving global, life-science innovation leaders in pricing, reimbursement, health economics and policy functions he had a unique chance to distil the essence of capturing and communicating value of medical innovation. With CENTIVIS, he and his passionate team aspire to share this experience with you.
Let us support you with access & policy 1. capability building, 2. product specific consulting solutions and 3. interim management.